News – Page 221 – Endpoints News

Vertex founder Joshua Boger on surviving downturns, 'painful' partnerships, and the importance of culture: #JPM24

Last year

Dyne closes $345M public offering a week after early positive data for dystrophy drugs

Last year

Boehringer allocates €120M to boost production of Jardiance in Greek plant

Last year

Ex-Celgene chief Mark Alles, former Goldfinch Bio leader Tony Johnson are back in the game as CEOs

Last year

J&J extends ‘Save Legs’ campaign to drive awareness of peripheral artery disease

Last year

Novartis reportedly backs off acquisition of Cytokinetics – WSJ

Last year

Biogen ends agreement with Acorda for multiple sclerosis drug Fampyra

Last year

Want to make better pharma ads? Try using humor and more branding, Kantar analyst says

Last year

FDA determines GLP-1s not linked to suicidal thoughts or actions in preliminary review

Last year

FDA develops pilot to harmonize international gene therapy regulations

Last year

Praxis prices $150M public stock offering ahead of four topline neuro readouts in 2024

Last year

WuXi Bio expands US presence; FujiFilm boosts autoinjector services; SpectronRx to make prostate cancer radioligand

Last year

Case against Gilead for delaying release of safer HIV drug on solid ground, court rules

Last year

Emergent nabs US government contract of up to $235.8M for anthrax vaccine

Last year

Greg Verdine’s LifeMine eyes the clinic next year with T-cell immunosuppressive and antifungal: #JPM24

Last year

Dermavant's PhIII eczema data; Oxford's Nipah vaccine; Inventiva's €25M lifeline

Last year

BioNTech pays $20M upfront for two monoclonal antibodies from China's WuXi Biologics

Last year

FDA approves import of French antibiotics to combat syphilis drug shortage

Last year

Madrigal says it's 'well on the way' to potential NASH launch ahead of FDA decision: #JPM24

Last year

Cigna CEO says the insurance giant is paying attention to healthcare services to buy: #JPM24

Last year

#JPM24 quick hits: Ionis on partnership’s pros and cons; Novo Ventures has $600M to spend; Are small molecules ...

Last year

Sanofi says it may look at next generation of weight loss drugs: #JPM24

Last year

How generic drug sponsors can ask FDA to reconsider applications: new draft guidance explains

Last year

FDA commissioner says agency cannot be the only regulator of AI in digital health

Last year

First page Previous page 218 219 220221222 223 224 Next page Last page